CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 20 8089 7893 support@capital.com

Perdagangan Nautilus Biotechnology, Inc. - NAUT CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.030779%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.013666%
Waktu biaya inap 22:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 1.50-5.07
Average Volume (10 days) 150.71K
Average Volume (3 months) 3.18M
Market Cap 256.93M
P/E Ratio -100.00K
Shares Outstanding 124.72M
Revenue N/A
EPS -0.49
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Feb 23, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Nautilus Biotechnology, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2019 2020 2021
Total revenue 0 0 0
Total Operating Expense 10.11 15.744 50.498
Selling/General/Admin. Expenses, Total 1.622 3.312 21.146
Research & Development 8.488 12.432 28.352
Operating Income -10.11 -15.744 -50.498
Other, Net 0.492 0.125 0.183
Net Income Before Taxes -9.618 -15.619 -50.315
Net Income After Taxes -9.618 -15.619 -50.315
Net Income Before Extra. Items -9.618 -15.619 -50.315
Net Income -9.618 -15.619 -50.315
Income Available to Common Excl. Extra. Items -9.618 -15.619 -50.315
Income Available to Common Incl. Extra. Items -9.618 -15.619 -50.315
Diluted Net Income -9.618 -15.619 -50.315
Diluted Weighted Average Shares 124.094 124.094 124.303
Diluted EPS Excluding Extraordinary Items -0.07751 -0.12586 -0.40478
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.07751 -0.12586 -0.40478
Depreciation / Amortization 1
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 0 0 0 0 0
Total Operating Expense 8.417 10.697 14.568 16.816 16.022
Selling/General/Admin. Expenses, Total 3.582 4.317 6.324 6.923 6.364
Research & Development 4.835 6.38 8.244 9.893 9.658
Operating Income -8.417 -10.697 -14.568 -16.816 -16.022
Other, Net 0.008 -0.016 0.064 0.127 0.259
Net Income Before Taxes -8.409 -10.713 -14.504 -16.689 -15.763
Net Income After Taxes -8.409 -10.713 -14.504 -16.689 -15.763
Net Income Before Extra. Items -8.409 -10.713 -14.504 -16.689 -15.763
Net Income -8.409 -10.713 -14.504 -16.689 -15.763
Income Available to Common Excl. Extra. Items -8.409 -10.713 -14.504 -16.689 -15.763
Income Available to Common Incl. Extra. Items -8.409 -10.713 -14.504 -16.689 -15.763
Diluted Net Income -8.409 -10.713 -14.504 -16.689 -15.763
Diluted Weighted Average Shares 124.094 124.094 124.094 124.303 124.419
Diluted EPS Excluding Extraordinary Items -0.06776 -0.08633 -0.11688 -0.13426 -0.12669
Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
Diluted Normalized EPS -0.06776 -0.08633 -0.11688 -0.13426 -0.12669
  • Annual
  • Quarterly
2019 2020 2021
Total Current Assets 16.964 77.659 349.222
Cash and Short Term Investments 16.659 76.742 345.729
Cash & Equivalents 0.595 36.607 185.619
Short Term Investments 16.064 40.135 160.11
Prepaid Expenses 0.305 0.917 3.493
Total Assets 18.542 85.011 398.45
Property/Plant/Equipment, Total - Net 1.119 6.213 31.86
Property/Plant/Equipment, Total - Gross 1.868 7.498 33.854
Accumulated Depreciation, Total -0.749 -1.285 -1.994
Other Long Term Assets, Total 0.459 1.139 0.997
Total Current Liabilities 0.49 3.018 5.812
Accounts Payable 0.289 0.47 1.723
Accrued Expenses 0.201 2.548 4.089
Notes Payable/Short Term Debt 0 0 0
Total Liabilities 0.49 6.314 34.874
Total Long Term Debt 0 0 0
Other Liabilities, Total 0 3.296 29.062
Total Equity 18.052 78.697 363.576
Preferred Stock - Non Redeemable, Net 32.561 108.418 0
Common Stock 0.001 0.001 0.012
Additional Paid-In Capital 0.189 0.6 444.388
Retained Earnings (Accumulated Deficit) -14.706 -30.325 -80.64
Other Equity, Total 0.007 0.003 -0.184
Total Liabilities & Shareholders’ Equity 18.542 85.011 398.45
Total Common Shares Outstanding 124.094 124.094 124.303
Long Term Investments 16.371
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 69.445 374.628 352.222 349.222 327.065
Cash and Short Term Investments 67.837 373.144 347.345 345.729 324.117
Cash & Equivalents 51.803 288.387 190.241 185.619 188.622
Short Term Investments 16.034 84.757 157.104 160.11 135.495
Prepaid Expenses 1.608 1.484 4.877 3.493 2.948
Total Assets 76.148 393.275 385.347 398.45 384.673
Property/Plant/Equipment, Total - Net 2.889 2.769 5.731 31.86 31.693
Property/Plant/Equipment, Total - Gross 4.388 4.533 7.772 33.854 33.968
Accumulated Depreciation, Total -1.499 -1.764 -2.041 -1.994 -2.275
Other Long Term Assets, Total 3.814 0.612 0.767 0.997 0.997
Total Current Liabilities 4.525 3.231 4.209 5.812 6.406
Accounts Payable 2.12 1.229 1.498 1.723 1.487
Accrued Expenses 2.405 2.002 2.711 4.089 4.919
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 4.525 3.231 7.5 34.874 34.964
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0 0 3.291 29.062 28.558
Total Equity 71.623 390.044 377.847 363.576 349.709
Preferred Stock - Non Redeemable, Net 108.418 0 0
Common Stock 0.001 0.012 0.012 0.012 0.012
Additional Paid-In Capital 1.936 439.489 441.795 444.388 446.654
Retained Earnings (Accumulated Deficit) -38.734 -49.447 -63.951 -80.64 -96.403
Other Equity, Total 0.002 -0.01 -0.009 -0.184 -0.554
Total Liabilities & Shareholders’ Equity 76.148 393.275 385.347 398.45 384.673
Total Common Shares Outstanding 124.094 124.094 124.094 124.303 124.457
Long Term Investments 15.266 26.627 16.371 24.918
  • Annual
  • Quarterly
2019 2020 2021
Net income/Starting Line -50.315
Cash From Operating Activities -39.241
Cash From Operating Activities 1.019
Non-Cash Items 10.077
Changes in Working Capital -0.022
Cash From Investing Activities -138.964
Capital Expenditures -2.269
Other Investing Cash Flow Items, Total -136.695
Cash From Financing Activities 327.447
Financing Cash Flow Items 327.28
Issuance (Retirement) of Stock, Net 0.167
Net Change in Cash 149.242
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -8.409 -19.122 -33.626 -50.315 -15.763
Cash From Operating Activities -6.253 -14.545 -28.722 -39.241 -12.335
Cash From Operating Activities 0.214 0.479 0.756 1.019 0.281
Non-Cash Items 1.864 4.129 6.811 10.077 2.661
Changes in Working Capital 0.078 -0.031 -2.663 -0.022 0.486
Cash From Investing Activities 23.518 -61.048 -145.028 -138.964 15.182
Other Investing Cash Flow Items, Total 23.518 -60.035 -143.745 -136.695 15.663
Cash From Financing Activities -2.069 327.373 327.384 327.447 0.156
Financing Cash Flow Items -2.069 327.327 327.28 327.28 0
Net Change in Cash 15.196 251.78 153.634 149.242 3.003
Capital Expenditures -1.013 -1.283 -2.269 -0.481
Issuance (Retirement) of Stock, Net 0.046 0.104 0.167 0.156
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Mallick (Parag) Individual Investor 16.5806 20679892 200000 2022-04-18 LOW
Andreessen Horowitz Venture Capital 14.1544 17653917 0 2022-09-30 LOW
Perceptive Advisors LLC Private Equity 7.3051 9111151 0 2022-09-30 LOW
Vulcan Capital Management Inc Corporation 5.7511 7172985 0 2022-04-18
Madrona Venture Group, LLC Venture Capital 4.8273 6020770 0 2022-09-30 LOW
ARYA Sciences Holdings III Corporation 3.3246 4146500 3647500 2022-04-18
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.0098 2506664 -42423 2022-09-30 LOW
Comprehensive Financial Management LLC Investment Advisor 1.7836 2224619 0 2022-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.7452 2176689 -3631 2022-09-30 LOW
Bain Capital Life Sciences Investors, LLC Investment Advisor 1.6035 2000000 0 2022-09-30 LOW
Nazem (Farzad) Individual Investor 1.5139 1888146 0 2022-04-18 LOW
Tikvah Management LLC Hedge Fund 1.1938 1488895 0 2022-09-30 MED
Amazon.com Inc Investment Advisor 1.1682 1457055 0 2022-12-31 LOW
ArchPoint Investors, LLC Investment Advisor 1.1622 1449551 0 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7657 955069 4290 2022-09-30 LOW
Ally Bridge Group NY LLC Investment Advisor/Hedge Fund 0.6606 823974 -256592 2022-09-30 HIGH
Rubric Capital Management LP Hedge Fund 0.5994 747607 0 2022-09-30 MED
Nantahala Capital Management, LLC Hedge Fund 0.5254 655338 -129460 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.523 652325 72142 2022-09-30 LOW
RTW Investments L.P. Investment Advisor/Hedge Fund 0.4811 600000 -500000 2022-09-30 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
+485000+

Trader

65000+

Klien aktif per bulan

$48000000+

Volume investasi per bulan

$28000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Biotechnology & Medical Research (NEC)

2701 Eastlake Ave East
Suite 202
SEATTLE
WASHINGTON 98102
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,566.80 Price
-0.450% 1D Chg, %
Biaya inap posisi Long -0.0183%
Biaya inap posisi short 0.0071%
Waktu biaya inap 22:00 (UTC)
Spread 3.0

Natural Gas

2.41 Price
-2.390% 1D Chg, %
Biaya inap posisi Long -0.1138%
Biaya inap posisi short 0.0796%
Waktu biaya inap 22:00 (UTC)
Spread 0.005

Oil - Crude

73.41 Price
-3.570% 1D Chg, %
Biaya inap posisi Long -0.0223%
Biaya inap posisi short 0.0065%
Waktu biaya inap 22:00 (UTC)
Spread 0.03

BTC/USD

23,357.65 Price
-0.480% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 60.00

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 485.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda